Skip to content
Bayer Pharmaceuticals
-
-
-
-
-
-
-
-
Bayer’s strategic overhaul unveiled amidst challenging q3 performance
GERMANY — Bayer Pharmaceuticals is poised for a transformative shake-up following a Q3 financial report that CEO Bill Anderson deemed “not acceptable.” Expressing dissatisfaction with…
-
Bayer and Hologic collaborate to advance contrast agent-enhanced mammography
USA — Bayer and Hologic have joined forces with a singular mission: to revolutionize breast cancer scans. Their visionary approach combines Bayer’s cutting-edge imaging contrast…
-
Bayer’s new CEO sets sights on radical change to boost stock performance
GERMANY —Bayer’s newly appointed CEO, Bill Anderson, is planning a strategic overhaul that begins with trimming down management positions to expedite decision-making in a bold…